This inventor holds 1 USPTO granted patent. Top assignee: Fox Chase Cancer Center. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Aqqaluk Peterson: Innovator in Diabetes Risk Assessment
Introduction
Aqqaluk Peterson is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of diabetes research through his innovative patent. His work focuses on assessing the risk of diabetes-associated pathologic conditions, which is crucial for improving patient outcomes.
Latest Patents
Aqqaluk Peterson holds a patent for a method that assesses the risk of diabetes-associated pathologic conditions. This method involves determining the concentrations of one or more carbohydrates phosphorylated at a secondary hydroxyl, including fructose-3-phosphate and sorbitol-3-phosphate, in biological tissue or cells of diabetic patients. The assessment is conducted using techniques such as 31P NMR Spectroscopy and High Performance Liquid Chromatography (HPLC). Elevated levels of these phosphorylated carbohydrates, relative to a prescribed standard or threshold level, indicate an increased risk for developing the degenerative complications of diabetes. This innovative method allows for the determination of the relative concentrations of such carbohydrates, enabling the assessment of a patient's risk for developing diabetic complications and the efficacy of therapeutic interventions.
Career Highlights
Aqqaluk Peterson is affiliated with the Fox Chase Cancer Center, where he continues to advance his research in diabetes and related fields. His work is instrumental in bridging the gap between laboratory research and clinical applications, ultimately benefiting patients at risk of diabetes complications.
Collaborations
Some of Aqqaluk Peterson's notable coworkers include Benjamin S Szwergold and Truman R Brown. Their collaborative efforts contribute to the ongoing research and development in the field of diabetes risk assessment.
Conclusion
Aqqaluk Peterson's innovative approach to assessing diabetes risk through his patented method represents a significant advancement in medical research. His contributions are vital for improving the understanding and management of diabetes-related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
